1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004
2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004
3. Sartor A, Oudard S, Ozguroglu M, et al. Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel: final results of a multinational phase III trial (TROPIC). Presented at: ASCO Genitourinary Cancers Symposium; March 5-7, 2010; San Francisco, California (Abstract 9).
4. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009
5. Abiraterone. Cougar Biotechnology;Madan;IDrugs,2006